Literature DB >> 25404185

Chronic kidney disease and premature ageing of the adaptive immune response.

Michiel G H Betjes1, Nicolle H R Litjens.   

Abstract

Los of renal function is associated with uremia-associated immune deficiency, which contributes significantly to the mortality and morbidity of end-stage renal disease (ESRD) patients. In this review, the effect of ESRD on the adaptive cellular immune system is discussed. Progressive loss of renal function causes a preferential loss of number and function of lymphoid cells. More in depth analysis of these changes reveals a loss of thymic function, attrition of telomeres, and expanded memory T cell population, which is compatible with the concept of premature immunological ageing. Latency for cytomegalovirus is associated with more profound changes and the expansion of a unique pro-inflammatory, cytotoxic subset of CD4-positive CD28null T cells. Epigenetically, modifications in hematopoietic stem cells may underlie uremia-associated immunological ageing, which is not reversed by kidney transplantation. Possible therapeutic options to reverse or halt uremia-associated immunological ageing are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25404185     DOI: 10.1007/s11934-014-0471-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  39 in total

Review 1.  A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.

Authors:  Michiel G H Betjes; Ruud W J Meijers; Lucia E A de Wit; Nicolle H R Litjens
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

2.  Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature.

Authors:  Pablo J van de Berg; Kirstin M Heutinck; Robin Raabe; Robert C Minnee; Si La Young; Karlijn A van Donselaar-van der Pant; Frederike J Bemelman; Rene A van Lier; Ineke J ten Berge
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

Review 3.  CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.

Authors:  J E Scherberich; W A Nockher
Journal:  Clin Chem Lab Med       Date:  1999-03       Impact factor: 3.694

Review 4.  Systemic consequences of poor oral health in chronic kidney disease patients.

Authors:  Harun Akar; Gulcan Coskun Akar; Juan Jesús Carrero; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

5.  Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease.

Authors:  Martijn Anton Verkade; Corné Johan van Druningen; Leonard Maria Bernardus Vaessen; Dennis Adriaan Hesselink; Willem Weimar; Michiel Gerardus Henricus Betjes
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

Review 6.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

7.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

8.  Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans.

Authors:  Liset Westera; Julia Drylewicz; Ineke den Braber; Tendai Mugwagwa; Iris van der Maas; Lydia Kwast; Thomas Volman; Elise H R van de Weg-Schrijver; István Bartha; Gerrit Spierenburg; Koos Gaiser; Mariëtte T Ackermans; Becca Asquith; Rob J de Boer; Kiki Tesselaar; José A M Borghans
Journal:  Blood       Date:  2013-08-14       Impact factor: 22.113

9.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

10.  Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.

Authors:  Michiel G H Betjes; Willem Weimar; Nicolle H R Litjens
Journal:  J Transplant       Date:  2013-10-01
View more
  17 in total

1.  The role of age-related T-cell differentiation in patients with renal replacement therapy.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Volker Eckstein; Anthony Ho; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunol Cell Biol       Date:  2017-07-19       Impact factor: 5.126

2.  The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.

Authors:  Jiang-Tao Tang; Brenda C de Winter; Dennis A Hesselink; Ferdi Sombogaard; Lan-Lan Wang; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2016-11-30       Impact factor: 4.335

3.  Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Authors:  L Huang; A W Langerak; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2016-08-19       Impact factor: 4.330

4.  End-Stage Renal Disease Causes Skewing in the TCR Vβ-Repertoire Primarily within CD8+ T Cell Subsets.

Authors:  Ling Huang; Michiel G H Betjes; Mariska Klepper; Anton W Langerak; Carla C Baan; Nicolle H R Litjens
Journal:  Front Immunol       Date:  2017-12-15       Impact factor: 7.561

5.  pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients.

Authors:  Ling Huang; Nicolle H R Litjens; Nynke M Kannegieter; Mariska Klepper; Carla C Baan; Michiel G H Betjes
Journal:  Immun Ageing       Date:  2017-06-19       Impact factor: 6.400

6.  V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients.

Authors:  Henry Sung-Ching Wong; Che-Mai Chang; Chih-Chin Kao; Yu-Wen Hsu; Xiao Liu; Wen-Chang Chang; Mai-Szu Wu; Wei-Chiao Chang
Journal:  J Biomed Sci       Date:  2017-07-11       Impact factor: 8.410

7.  Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.

Authors:  Nadezhda A Wall; C Coral Dominguez-Medina; Sian E Faustini; Charlotte N Cook; Andrew McClean; Mark D Jesky; Marisol Perez-Toledo; Matthew D Morgan; Alexandra G Richter; Charles J Ferro; Paul Cockwell; Paul A Moss; Ian R Henderson; Lorraine Harper; Adam F Cunningham
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

8.  Epidemiology and outcomes of anal abscess in patients on chronic dialysis: a 14-year retrospective study.

Authors:  Meng-Hsuan Hsieh; Yueh-An Lu; George Kuo; Chao-Yu Chen; Wei-Chiao Sun; YuJr Lin; Ya-Chung Tian; Hsiang-Hao Hsu
Journal:  Clinics (Sao Paulo)       Date:  2019-03-21       Impact factor: 2.365

Review 9.  Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.

Authors:  Caroline Lamarche; Ioan-Andrei Iliuta; Thomas Kitzler
Journal:  Can J Kidney Health Dis       Date:  2019-04-29

10.  Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging.

Authors:  Vincenzo Sepe; Marilena Gregorini; Teresa Rampino; Pasquale Esposito; Rosanna Coppo; Francesco Galli; Carmelo Libetta
Journal:  BMC Nephrol       Date:  2019-11-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.